• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Afya Limited

    9/18/24 4:03:22 PM ET
    $AFYA
    Other Consumer Services
    Real Estate
    Get the next $AFYA alert in real time by email
    SC 13D/A 1 dp218166_sc13da-30.htm FORM SC 13D/A

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13D/A

     

    Under the Securities Exchange of 1934

    (Amendment No. 30)

     

    Afya Limited
    (Name of Issuer)

     

    Class A Common Shares, par value $0.00005 per share
    (Title of Class of Securities)

     

    G01125106
    (CUSIP Number)

     

    Denise Abel
    Bertelsmann SE & Co. KGaA
    Carl-Bertelsmann-Strasse 270
    33311 Gütersloh, Germany

    with copies to:

    Michael Davis, Esq.
    Davis Polk & Wardwell LLP
    450 Lexington Avenue
    New York, New York 10017

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

      September 18, 2024 (September 17, 2024)  
      (Date of Event which Requires Filing of this Statement)  

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.¨

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    CUSIP No. G01125106  

     

    1

    NAME OF REPORTING PERSON

     

    Bertelsmann SE & Co. KGaA

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨
    (b) x
    3

    SEC USE ONLY

      

    4

    SOURCE OF FUNDS (See Instructions)

     

    WC

    5

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

    ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Germany

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

     

    —

    8

    SHARED VOTING POWER

     

    57,906,915

    9

    SOLE DISPOSITIVE POWER

     

    57,906,915

    10

    SHARED DISPOSITIVE POWER

     

    —

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    57,906,915 (1)

    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

    ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    71.97% (2)(3)

    14

    TYPE OF REPORTING PERSON (See Instructions)

     

    CO

    1 

     

    1

    NAME OF REPORTING PERSON

     

    Erste WV Gütersloh GmbH

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ¨
    (b) x
    3

    SEC USE ONLY

     

    4

    SOURCE OF FUNDS (See Instructions)

     

    WC

    5

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

    ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Germany

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

     

    —

    8

    SHARED VOTING POWER

     

    57,906,915

    9

    SOLE DISPOSITIVE POWER

     

    57,906,915

    10

    SHARED DISPOSITIVE POWER

     

    —

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    57,906,915 (1)

    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

     

    ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    71.97% (2)(3)

    14

    TYPE OF REPORTING PERSON (See Instructions)

     

    CO

     

    (1) Aggregate amount beneficially owned by Bertelsmann SE & Co. KGaA (“Bertelsmann”) and Erste WV Gütersloh GmbH, a wholly-owned direct subsidiary of Bertelsmann (“Erste” and collectively with Bertelsmann, the “Reporting Person”) consists of 34,074,134 Class B common shares and 23,832,781 Class A common shares held of record by the Reporting Person. Each Class B common share held of record by the Reporting Person is convertible into one Class A common share at the option of its holder at any time.
    (2) Represents the quotient obtained by dividing (a) the number of Class B common shares and Class A common shares beneficially owned by the Reporting Person as set forth in Row 11 by (b) the sum of (i) 46,390,124 Class A common shares outstanding as of June 30, 2024 as reported by the Issuer in its Current Report on Form 6-K, filed with the Securities and Exchange Commission (the “Commission”) on August 14, 2024 (as reduced by the number of treasury shares reported therein), and (ii) the aggregate number of Class B common shares beneficially owned by the Reporting Person. The aggregate number of Class B common shares beneficially owned by the Reporting Person as set forth in clauses “(a)” and “(b)” of this footnote are treated as converted into Class A common shares only for the purpose of computing the percentage ownership of the Reporting Person. As of September 30, 2023, the number of Class A common shares outstanding was 44,009,699 and the percentage beneficially owned was 58.06%.
    (3) Each Class A common share is entitled to one vote, and each Class B common share is entitled to ten votes. The percentage reported does not reflect the ten for one voting power of the Class B common shares because the Class B common shares are treated as converted into Class A common shares for the purpose of this report.

    2 

     

    Explanatory Note

     

    This Amendment No. 30 (the “Amendment”) amends and supplements the Schedule 13D filed by the Reporting Person on August 10, 2021 (the “Original Schedule 13D”, as further amended on March 4, 2022, “Amendment No. 1”, as further amended on April 18, 2022, “Amendment No. 2”, as further amended on April 25, 2022, “Amendment No. 3,” as further amended on May 4, 2022, “Amendment No. 4,” as further amended on May 23, 2022, “Amendment No. 5,” as further amended on May 27, 2022, “Amendment No. 6,” as further amended on August 1, 2022, “Amendment No. 7,” as further amended on August 31, 2022, “Amendment No. 8,” as further amended on September 23, 2022, “Amendment No. 9,” as further amended on October 24, 2022, “Amendment No. 10,” as further amended on November 9, 2022, “Amendment No. 11,” as further amended on November 29, 2022, “Amendment No. 12,” as further amended on December 16, 2022, “Amendment No. 13,” as further amended on December 21, 2022, “Amendment No. 14,” as further amended on January 12, 2023, “Amendment No. 15,” as further amended on February 23, 2023, “Amendment No. 16,” as further amended on March 29, 2023, “Amendment No. 17,” as further amended on May 1, 2023, “Amendment No. 18,” as further amended on June 20, 2023, “Amendment No. 19,” as further amended on July 25, 2023, “Amendment No. 20,” as further amended on September 7, 2023, “Amendment No. 21,” as further amended on October 31, 2023, “Amendment No. 22,” as further amended on December 12, 2023, “Amendment No. 23,” as further amended on February 12, 2024, “Amendment No. 24,” as further amended on March 19, 2024, “Amendment No. 25,” as further amended on May 7, 2024, “Amendment No. 26,” as further amended on May 22, 2024, “Amendment No. 27,” as further amended on June 27, 2024, “Amendment No. 28,” as further amended on July 23, 2024, “Amendment No. 29,”and, as amended and supplemented by this Amendment, the “Schedule 13D”). Except as specifically provided herein, this Amendment does not modify any of the information previously reported on the Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 13, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 27, Amendment No. 28 or Amendment No. 29. Capitalized terms not otherwise defined in this Amendment shall have the same meanings ascribed thereto in the Original Schedule 13D. This Schedule 13D relates to the Class A common shares, par value $0.00005, of Afya Limited, an exempted liability company incorporated under the laws of the Cayman Islands (the “Issuer”), having its registered offices at Alameda Oscar Niemeyer, No. 119, Salas 502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima, Minas Gerais Brazil.

     

    3 

     

    Item 3.

    Source and Amount of Funds or Other Consideration

     

     

    This Amendment No. 30 amends and supplements Item 3 of the Original Schedule 13D (as amended by Amendment No. 3, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 25, Amendment No. 26, Amendment No. 28 and Amendment No. 29) as follows:

     

    The Reporting Person purchased an additional 901,639 Class A common shares pursuant to the Trading Plan for a purchase price of $15,374,475.81, or an average of $17.05 per Class A common share. Such price was funded by the Reporting Person through internally generated funds.

     

    Item 5. Interest in Securities of the Issuer.

     

    This Amendment No. 30 amends and supplements Item 5 of the Original Schedule 13D (as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, Amendment No. 14, Amendment No. 15, Amendment No. 16, Amendment No. 17, Amendment No. 18, Amendment No. 19, Amendment No. 20, Amendment No. 21, Amendment No. 22, Amendment No. 23, Amendment No. 24, Amendment No. 25, Amendment No. 26, Amendment No. 28 and Amendment No. 29) as follows:

     

    (a) The information relating to the beneficial ownership of Class A common shares by the Reporting Person as set forth in rows 7 through 13 of the cover pages hereto is incorporated by reference. The Reporting Person is the beneficial owner of 23,832,781 Class A common shares, which represents 51.37% of the Class A common shares outstanding based on 46,390,124 Class A common shares outstanding as of June 30, 2024 as reported by the Issuer in its Current Report on Form 6-K, filed with the Commission on August 14, 2024 (as reduced by the number of treasury shares reported therein). Except as set forth in this Item 5(a), the Reporting Person does not own beneficially any Class A common shares. The Reporting Person will provide upon request of the SEC staff the full information regarding the number of shares purchased or sold at each separate price.

     

    (b) The Reporting Person has shared power to vote and dispose of 23,832,781 Class A common shares.

     

    (c) The Reporting Person has purchased the following Class A common shares in open market transactions pursuant to the Trading Plan since the filing of the Schedule 13D/A on July 23, 2024:

     

    4 

     

    Transaction Date

      Class A Common Shares Purchased   Average Price Per Share
    July 23, 2024   6,773   17.93
    July 25, 2024   22,961   17.96
    July 26, 2024   30,670   17.74
    July 29, 2024   23,001   17.96
    July 30, 2024   29,391   17.89
    July 31, 2024   28,764   17.95
    August 1, 2024   7,257   17.87
    August 2, 2024   29,102   17.64
    August 5, 2024   29,391   17.33
    August 6, 2024   26,232   16.73
    August 7, 2024   26,922   16.77
    August 8, 2024   26,669   16.98
    August 9, 2024   26,922   17.23
    August 12, 2024   20,866   17.67
    August 13, 2024   27,540   17.61
    August 14, 2024   27,540   17.67
    August 15, 2024   25,058   17.84
    August 23, 2024   8,004   18.00
    August 27, 2024   20,318   17.97
    August 28, 2024   9,441   17.96
    August 29, 2024   26,442   17.46
    August 30, 2024   24,422   17.35
    September 3, 2024   26,442   16.74
    September 4, 2024   33,178   16.42
    September 5, 2024   33,178   16.83
    September 6, 2024   33,178   16.86
    September 9, 2024   33,178   16.47
    September 10, 2024   29,873   16.09
    September 11, 2024   34,783   15.89
    September 12, 2024   32,571   15.86
    September 13, 2024   34,783   16.09
    September 16, 2024   34,783   16.44
    September 17, 2024   37,541   16.59
    September 18, 2024   34,465   16.65

    5 

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: September 18, 2024    
         
      BERTELSMANN SE & CO. KGAA
         
         
      By:  ppa /s/ Martin Dannhoff
      Name:  Martin Dannhoff
      Title:   SVP Corporate Legal
         
      By: ppa /s/ Denise Abel
      Name: Denise Abel
      Title:  SVP Corporate Legal
         
         
      ERSTE WV GÜTERSLOH GMBH
         
         
      By: /s/ Martin Dannhoff
      Name: Martin Dannhoff
      Title:   Director
         
      By: /s/ Denise Abel
      Name: Denise Abel
      Title:   Director

     

    6 

    Get the next $AFYA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AFYA

    DatePrice TargetRatingAnalyst
    3/11/2025$19.00 → $17.00Equal-Weight → Underweight
    Morgan Stanley
    1/31/2025$18.00 → $15.00Neutral → Sell
    Citigroup
    12/3/2024$16.00Sell
    Goldman
    8/30/2024$19.50Neutral
    UBS
    1/29/2024$23.00Neutral
    Citigroup
    1/22/2024$20.50 → $23.00Overweight → Equal-Weight
    Morgan Stanley
    10/13/2023$16.50 → $20.50Equal-Weight → Overweight
    Morgan Stanley
    4/8/2022$18.00 → $19.00Neutral → Outperform
    Credit Suisse
    More analyst ratings

    $AFYA
    SEC Filings

    See more
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/8/25 4:13:04 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/8/25 4:09:46 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by Afya Limited

      6-K - Afya Ltd (0001771007) (Filer)

      5/7/25 4:18:35 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Afya Limited Announces First-Quarter 2025 Financial Results

      Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2025 Highlights 1Q25 Net Revenue increased 16.4% YoY to R$936.4 million. Net Revenue excluding acquisitions increased 10.9%, reaching R$891.5 million. 1Q25 Adjusted

      5/8/25 8:11:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Closing of the Acquisition of FACULDADE ÚNICA DE CONTAGEM

      Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the company on December 19th, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Masterclass Ltda. ("FACULDADE ÚNICA DE CONTAGEM" or "FUNIC"), located in Contagem, a city in the metropolitan area of Belo Horizonte, the capital of the State of Minas Gerais. The acquisition contributes 60 medical school seats to Afya. FUNIC is pre-operational, with leased real estate prepared for a medi

      5/7/25 5:27:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Fourth Quarter and Full-Year 2024 Financial Results

      Impressive Adjusted EBITDA Margin Expansion Expressive Cash Generation First Dividend Announcement Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2024 Highlights 4Q24 Net Revenue increased 16.3% YoY to R$849.0 million. Net Revenue excluding acquisitions increased 12.0%, reaching R$817.8 million. 4Q24 Adjust

      3/13/25 5:45:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Financials

    Live finance-specific insights

    See more
    • Afya Limited Announces First-Quarter 2025 Financial Results

      Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2025 Highlights 1Q25 Net Revenue increased 16.4% YoY to R$936.4 million. Net Revenue excluding acquisitions increased 10.9%, reaching R$891.5 million. 1Q25 Adjusted

      5/8/25 8:11:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces Fourth Quarter and Full-Year 2024 Financial Results

      Impressive Adjusted EBITDA Margin Expansion Expressive Cash Generation First Dividend Announcement Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2024 Highlights 4Q24 Net Revenue increased 16.3% YoY to R$849.0 million. Net Revenue excluding acquisitions increased 12.0%, reaching R$817.8 million. 4Q24 Adjust

      3/13/25 5:45:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya Limited Announces First Dividend Distribution of R$129.8 Million

      Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), Brazil's leading medical education group and provider of medical practice solutions, announced that its board of directors (the "Board") approved its first distribution of a cash dividend. On March 12, 2025, Afya's Board declared a cash dividend of R$129.8 million, representing 20% of the Company's consolidated net income of R$648.9 million for the year ended December 31, 2024. This amounts to a dividend per share (DPS) of R$1.348923, payable in U.S. dollars on April 4, 2025, to shareholders of record as of the close of business on March 26, 2025. The payment will be made at the exchange rate (PTAX) published on March 13, 2

      3/13/25 4:57:00 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 5:15:03 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 4:21:17 PM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by Afya Limited

      SC 13G/A - Afya Ltd (0001771007) (Subject)

      11/14/24 4:18:15 PM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Afya downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Afya from Equal-Weight to Underweight and set a new price target of $17.00 from $19.00 previously

      3/11/25 7:14:11 AM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Afya downgraded by Citigroup with a new price target

      Citigroup downgraded Afya from Neutral to Sell and set a new price target of $15.00 from $18.00 previously

      1/31/25 8:29:57 AM ET
      $AFYA
      Other Consumer Services
      Real Estate
    • Goldman initiated coverage on Afya with a new price target

      Goldman initiated coverage of Afya with a rating of Sell and set a new price target of $16.00

      12/3/24 8:02:22 AM ET
      $AFYA
      Other Consumer Services
      Real Estate

    $AFYA
    Leadership Updates

    Live Leadership Updates

    See more
    • Afya Limited Announces that Whitebook was ranked as one of the 10 Top Apps in Brazil by Consumer Spend in 2020

      NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announces that its clinical decision software, WhiteBook, an app created by PEBMED, was ranked as one of the 10 Top Apps in Brazil by consumer spend in 2020 for the fifth year in a row. App Annie conducted the study, a website specialized in app analytics and app market data that combined data from iOS and Google Play that evaluates more than 8 million mobile app per year. In the top ten WhiteBook was among great apps such as Tinder, YouTube, Netflix, TikTok and others. Whitebook is a mobile and web application software that helps doctors and medical students to make

      1/15/21 8:55:10 AM ET
      $AFYA
      Other Consumer Services
      Real Estate